| Photodynamic therapy using rhodamine-123 as a new laser dye: biodistribution, metabolism and histology in New Zealand rabbits. | |
| | |
MedLine Citation:
|
PMID: 1992266 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Rhodamine-123 (Rh-123) has been tested recently as a new laser dye for photodynamic therapy of human tumors in vitro and in vivo. Prior to initiation of clinical studies of this technique, we evaluated the biodistribution, metabolism, and pathological changes of Rh-123 in rabbits after systemic, repetitive injections of the dye in escalating doses. At doses between 0.1 to 1 mg/kg of Rh-123 injected intramuscularly (IM) daily for 5 days, no local or systemic toxicity was observed during the 4 weeks of follow-up. The peak concentrations of Rh-123 in micrograms/g of tissue was distributed as follows: kidney (3.24) greater than heart (2.24) greater than spleen (1.77) greater than lung (0.61) greater than liver (0.38) greater than skin (0.30) greater than skeletal muscle (0.17) greater than genitals (0.13) greater than brain (0.04). The elimination of Rh-123 was very rapid, with the dye falling to 2.7% of peak concentration at 72 hours in the kidneys, and to undetectable levels at 240 hours postinjection in all organs, except the skin, which retained 3% of the peak level at 240 hours. The low toxicity and rapid metabolism of Rh-123 in this preclinical model suggests that the dye and Argon laser may represent an effective combination for treatment of superficial malignancies. |
| | |
Authors:
|
D J Castro; A Gaskin; R E Saxton; E Reisler; E Nishimura; S Y To; D O Rodgerson; L J Layfield; P B Tartell; D J Castro |
Related Documents
:
|
8366876 - Clinical efficacy and tolerability of saperconazole for tinea of glabrous skin. a repor... 10428646 - Effect of msc on the immune response of mice. 1421366 - Skin test inhibition by astemizole. 1314336 - Effects of methylguanidine on sodium and organic ion transport. 8366876 - Clinical efficacy and tolerability of saperconazole for tinea of glabrous skin. a repor... 10471426 - Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability s... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review |
Journal Detail:
|
Title: The Laryngoscope Volume: 101 ISSN: 0023-852X ISO Abbreviation: Laryngoscope Publication Date: 1991 Feb |
Date Detail:
|
Created Date: 1991-03-12 Completed Date: 1991-03-12 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 8607378 Medline TA: Laryngoscope Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 158-64 Citation Subset: IM |
Affiliation:
|
Division of Head and Neck Surgery, UCLA School of Medicine 90024-1624. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Body Weight / drug effects Coloring Agents / pharmacokinetics, therapeutic use* Drug Evaluation, Preclinical Female Heart / drug effects Kidney / drug effects, metabolism Male Myocardium / metabolism Photochemotherapy / methods* Rabbits Rhodamine 123 Rhodamines / pharmacokinetics, therapeutic use* Spleen / metabolism Tissue Distribution |
| Grant Support | |
ID/Acronym/Agency:
|
DC 00031/DC/NIDCD NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Coloring Agents; 0/Rhodamines; 62669-70-9/Rhodamine 123 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Electromyography of masticatory muscles in craniomandibular disorders.
Next Document: Characterization of cytokines present in middle ear effusions.